EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep13574.pdf
Reference50 articles.
1. Siegel, R., Naishadham, D. & Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11–30 (2013).
2. Meoni, G., Cecere, F. L., Lucherini, E. & Di Costanzo, F. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents. J. Geriatr. Oncol. 4, 282–290 (2013).
3. Memon, A. & Zawadzki Z. A. Malignant effusions: diagnostic evaluation and therapeutic strategy. Curr. Probl. Cancer 5, 1–30 (1981).
4. Johnston, W. W. The malignant pleural effusion: a review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 56, 905–909 (1985).
5. Goldstraw, P. et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J. Thorac. Oncol. 2, 706–714 (2007).
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Probing phosphorylation events in biological membranes: The transducer function;Biochimica et Biophysica Acta (BBA) - Biomembranes;2024-10
2. Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy;Medicine in Drug Discovery;2024-09
3. Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology‐proven malignant pleural effusions;Cancer Cytopathology;2024-08-29
4. An agent-based modelling framework to study growth mechanisms in EGFR-L858R mutant cell alveolar type II cells;Royal Society Open Science;2024-07
5. Modeling metastatic progression from cross-sectional cancer genomics data;Bioinformatics;2024-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3